Posted on 24/04/2017
Rayner will mark an important milestone next month: the 10-year anniversary of US Food and Drug Administration (FDA) approval of C-flex 570C monofocal Intraocular Lens (IOL) for commercial use in the United States of Ame...
Posted on 27/02/2017
March 02, 2017 – Worthing, United Kingdom. Rayner announced today that a selection of models in their Sulcoflex range of pseudophakic supplementary IOLs have received Chi...
Posted on 15/02/2017
In 2016, 773 Rayner IOLs were used to restore the sight of some of Bangladesh’s poorest and most isolated people, according to the recent Annual IMPACT partner report. There were no complications found during post-operative follow up visi...
Posted on 31/01/2017
Phoenix Equity Partners ("Phoenix"), a leading UK middle-market private equity firm, today announces an investment in Rayner Surgical Group (“Rayner” or “the Company”) alongside the current management team...
Posted on 16/01/2017
Following on from their European expansion in 2016 -- direct entry into the Italian cataract market and Read more
Posted on 18/11/2016
Italian-speaking surgeons can now find a solution to their needs more efficiently and with greater ease thanks to the launch of an Italian translation of our global website www.staging.rayner.com....
Posted on 4/11/2016
The honour of presenting the 2016 Rayner Medal Lecture was awarded to Dr Warren Hill and as UKISCRS Secretary Satis...
Posted on 31/10/2016
To mark the recent Annual National Customer Service Week Event, Rayner Employees were given the opportunity to shadow a member of the 9-strong international Customer Service team for an afternoon. This provided an ideal setting...
Posted on 3/10/2016
Rayner announced today that it has acquired Moorfields Pharmaceuticals.
The acquisition closed September 30, 2016.
Posted on 20/09/2016
The new-look Rayner booth -- designed specifically with RayOne® demos in mind -- was inundated with traffic. Surgeons clamored to experience the highly anticipated, fully preloaded IOL injection system at the recent XXXIV Congres...